tbuckley/cabot-search huggingface dataset:
Guidance for Development of Nonopioid Analgesics
Authors: Rita Rubin
Journal: JAMA (2022)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Fraction of exhaled nitric oxide is associated with disease burden in the German Asthma Net severe asthma cohort
Authors: Christina Bal, Marco Idzko, Sabina Škrgat, Andrea Koch, Katrin Milger, Christian Schulz, Sonja Zehetmayer, Eckard Hamelmann, Roland Buhl, Stephanie Korn
Journal: European Respiratory Journal (2022)

<b>In a severe asthma cohort of 1007 patients, high <i>F</i><sub>ENO</sub> was associated with chronic rhinosinusitis/polyps, later asthma onset, poor lung function and asthma control, low quality of life, frequent exacerbations and the need for maintenance OCS. #GANregistry</b> https://bit.ly/3sNrtIQ
CARDIOVASCULAR READMISSIONS IN CATHETER ABLATION VERSUS ANTIARRHYTHMIC MEDICAL THERAPY IN PATIENTS WITH ATRIAL FIBRILLATION - A SYSTEMATIC REVIEW AND META-ANALYSIS
Authors: Prashanth Singanallur, Radhika Deshpande, Albert Botchway, Yasser Al-Khadra, Nour Albast, Raad Al Tamimi, Manasik Abdu, Basma Al-bast, Mohamed Rafa Labedi
Journal: Journal of the American College of Cardiology (2022)
Abstract P4-01-14: The RXR agonist, IRX4204, increases the anti-tumor activity of HER2-targeted therapies in HER2-amplified breast cancer
Authors: Cassandra L Moyer, Abhijit Mazumdar, Jamal Hill, Martin E Sanders, Powel Brown
Journal: Cancer Research (2022)

Abstract Background: HER2 targeted monoclonal antibodies and tyrosine kinase inhibitors (TKI) are effective treatments for HER2-amplified primary tumors. However, the challenge persists that primary and acquired resistance to anti-HER2 therapy is common, and that anti-HER2 targeted therapies fail to achieve a cure in the metastatic setting. There is a critical need for safe and effective therapies that can overcome anti-HER2 drug resistance and eliminate breast cancer metastases. Here, we present data demonstrating the activity of IRX4204, a highly specific agonist of the nuclear retinoid X receptor (RXR), to inhibit the growth of HER2-amplified breast cancer cell lines alone and in combination with current anti-HER2 therapies. Methods: In vitro cell growth assays were conducted to evaluate the efficacy of IRX4204 alone and in combination with trastuzumab, tucatinib, neratinib or T-DM1, using a panel of breast cancer cell lines expressing various levels of HER2. A calculated coefficient of drug interaction (CDI) and isobologram analysis was used to assess the additive, synergistic or antagonistic effects of IRX4204 with each anti-HER2 targeted therapy. Results: IRX4204 treatment alone inhibited the growth of HER2-overexpressing cell lines, SkBr3, AU565, HCC1419 and ZR75-1 in vitro, but not the growth of HER2-normal cell lines MCF7, MDA-MB-231, or HCC1143. When combined with trastuzumab, tucatinib, neratinib or T-DM1, additive or synergistic effects were observed in all of the drug-sensitive cell lines. Moreover, IRX4204 in combination with neratinib or tucatinib inhibited the growth of a TKI-resistant breast cancer cell line (HCC1954). Conclusion: These data demonstrate a novel use of an RXR agonist, IRX4204, to inhibit the growth of HER2-amplified breast cancer cell lines and to enhance the activity of anti-HER2 therapy in vitro. These results also demonstrate that IRX4204 can overcome anti-HER2 resistance to inhibit the growth of HER2-positive cells. These data demonstrate that IRX4204 can enhance the anti-cancer activity of anti-HER2 therapies even in TKI-resistant cells. In vivo experiments and mechanistic studies are ongoing. Citation Format: Cassandra L Moyer, Abhijit Mazumdar, Jamal Hill, Martin E Sanders, Powel Brown. The RXR agonist, IRX4204, increases the anti-tumor activity of HER2-targeted therapies in HER2-amplified breast cancer [abstract]. In: Proceedings of the 2021 San Antonio Breast Cancer Symposium; 2021 Dec 7-10; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2022;82(4 Suppl):Abstract nr P4-01-14.
WIDELY SPLIT P WAVES IN A PATIENT WITH ATRIAL FLUTTER POST-CATHETER ABLATION ON AMIODARONE, DIASTOLIC DYSFUNCTION, AND ATRIAL ENLARGEMENT
Authors: Shengyuan Luo, Laith Derbas, Caleb Chiang, Henry Darchon Huang, Annabelle S. Volgman
Journal: Journal of the American College of Cardiology (2022)
Multiple motion encoding in phase-contrast MRI: A general theory and application to elastography imaging
Authors: Helge Herthum, Hugo Carrillo, Axel Osses, Sergio Uribe, Ingolf Sack, Cristóbal Bertoglio
Journal: Medical Image Analysis (2022)

While MRI allows to encode the motion of tissue in the magnetization's phase, it remains yet a challenge to obtain high fidelity motion images due to wraps in the phase for high encoding efficiencies. Therefore, we propose an optimal multiple motion encoding method (OMME) and exemplify it in Magnetic Resonance Elastography (MRE) data. OMME is formulated as a non-convex least-squares problem for the motion using an arbitrary number of phase-contrast measurements with different motion encoding gradients (MEGs). The mathematical properties of OMME are proved in terms of standard deviation and dynamic range of the motion's estimate for arbitrary MEGs combination which are confirmed using synthetically generated data. OMME's performance is assessed on MRE data from in vivo human brain experiments and compared to dual encoding strategies. The unwrapped images are further used to reconstruct stiffness maps and compared to the ones obtained using conventional unwrapping methods. OMME allowed to successfully combine several MRE phase images with different MEGs, outperforming dual encoding strategies in either motion-to-noise ratio (MNR) or number of successfully reconstructed voxels with good noise stability. This lead to stiffness maps with greater resolution of details than obtained with conventional unwrapping methods. The proposed OMME method allows for a flexible and noise robust increase in the dynamic range and thus provides wrap-free phase images with high MNR. In MRE, the method may be especially suitable when high resolution images with high MNR are needed.
THE DEGREE OF AORTIC AND MITRAL VALVE CALCIFICATION AND VALVULAR ABNORMALITIES IN OLDER ADULTS: THE ATHEROSCLEROTIC RISK IN COMMUNITY (ARIC) STUDY
Authors: Yasuyuki Honda, Frances Wang, Shoshana H. Ballew, Candace Howard-Claudio, Brandon Stacey, Suma H. Konety, Michael E. Hall, Patricia P. Chang, Seamus P. Whelton, Michael Blaha, Amil M. Shah, Kunihiro Matsushita
Journal: Journal of the American College of Cardiology (2022)
Testing Ripretinib against Sunitinib in GIST
Journal: Cancer Discovery (2022)

Abstract According to results from the phase III INTRIGUE trial, ripretinib is not superior to sunitinib as a second-line tyrosine kinase inhibitor for patients with gastrointestinal stromal tumors in terms of progression-free survival. However, ripretinib had a better safety profile and induced fewer grade 3–4 toxicities, including hypertension.
To-and-fro balloon technique for deployment of a lumen-apposing metal stent in highly solid walled-off necrosis of the pancreas
Authors: Tatsuya Sato, Tomotaka Saito, Yousuke Nakai, Mitsuhiro Fujishiro
Journal: Endoscopy (2022)

Lumen-apposing metal stents (LAMSs) have revolutionized endoscopic treatment of walled-off necrosis (WON) by allowing for effective drainage and subsequent endoscopic necrosectomy [1] [2]. However, it may be technically challenging to deploy a LAMS for a WON with little fluid content [3], which potentially inhibits insertion of the delivery and expansion of the distal stent flange [4].
Neurobiological Correlates of Change in Adaptive Behavior in Autism
Authors: Charlotte M. Pretzsch, Tim Schäfer, Michael V. Lombardo, Varun Warrier, Caroline Mann, Anke Bletsch, Chris H. Chatham, Dorothea L. Floris, Julian Tillmann, Afsheen Yousaf, Emily Jones, Tony Charman, Sara Ambrosino, Thomas Bourgeron, Guillaume Dumas, Eva Loth, Bethany Oakley, Jan K. Buitelaar, Freddy Cliquet, Claire S. Leblond, Simon Baron-Cohen, Christian F. Beckmann, Tobias Banaschewski, Sarah Durston, Christine M. Freitag, Declan G.M. Murphy, Christine Ecker
Journal: American Journal of Psychiatry (2022)

Objective: Autism spectrum disorder (ASD) is a lifelong neurodevelopmental condition that is associated with significant difficulties in adaptive behavior and variation in clinical outcomes across the life span. Some individuals with ASD improve, whereas others may not change significantly, or regress. Hence, the development of “personalized medicine” approaches is essential. However, this requires an understanding of the biological processes underpinning differences in clinical outcome, at both the individual and subgroup levels, across the lifespan. Methods: The authors conducted a longitudinal follow-up study of 483 individuals (204 with ASD and 279 neurotypical individuals, ages 6–30 years), with assessment time points separated by ∼12–24 months. Data collected included behavioral data (Vineland Adaptive Behavior Scale–II), neuroanatomical data (structural MRI), and genetic data (DNA). Individuals with ASD were grouped into clinically meaningful “increasers,” “no-changers,” and “decreasers” in adaptive behavior. First, the authors compared neuroanatomy between outcome groups. Next, they examined whether deviations from the neurotypical neuroanatomical profile were associated with outcome at the individual level. Finally, they explored the observed neuroanatomical differences’ potential genetic underpinnings. Results: Outcome groups differed in neuroanatomical features (cortical volume and thickness, surface area), including in “social brain” regions previously implicated in ASD. Also, deviations of neuroanatomical features from the neurotypical profile predicted outcome at the individual level. Moreover, neuroanatomical differences were associated with genetic processes relevant to neuroanatomical phenotypes (e.g., synaptic development). Conclusions: This study demonstrates, for the first time, that variation in clinical (adaptive) outcome is associated with both group- and individual-level variation in anatomy of brain regions enriched for genes relevant to ASD. This may facilitate the move toward better targeted/precision medicine approaches.
INSIGHT INTO THE ROLE OF SOCIOECONOMIC STATUS AND CHILD OPPORTUNITY ON SURGICAL OUTCOMES IN CONGENITAL HEART DISEASE
Authors: Joshua Mayourian, Ella Brown, Karina Javalkar, Emily Bucholz, Kimberlee Gauvreau, Rebecca Beroukhim, Eric Feins, John N. Kheir, John K. Triedman, Audrey Dionne
Journal: Journal of the American College of Cardiology (2022)
HOCM WITH NON POSTERIORLY-DIRECTED JET MR
Authors: Wisit Chanprasertpinyo, Krissada Meemook, Piyachat Pipatpongsopon, Bundit Naratreekoon, Kantathut Narongrit, Teerapat Yingchoncharoen
Journal: Journal of the American College of Cardiology (2022)
THROMBOINFLAMMATORY RESPONSE TO ON-PUMP CORONARY ARTERY BYPASS GRAFT SURGERY LEADS TO IMPAIRED PLATELET REACTIVITY IN PATIENTS WITH ACUTE CORONARY SYNDROME
Authors: Nadir Elamin, Thomas Nelson, William Parker, Frances Varian, Georgia Williamson, Hannah McMellon, Jessica Hanson, Janet Middle, Claire Bridge, Heather M. Judge, Norman Briffa, Steven Hunter, Robert F. Storey
Journal: Journal of the American College of Cardiology (2022)
NARROW COMPLEX TACHYARRHYTHMIA WITH ATRIOVENTRICULAR BLOCK IN THE SETTING OF EBSTEIN'S ANOMALY: RENEWING OF OPTIMIZED THERAPY FOR ARRYTHMIA
Authors: Tai Thien Tan Tri Truyen, Hai Dang, Thoai Nguyen, Pham Thao Vy Le, Huy Nguyen, San Tran, An Bui, Phat Tuan Nguyen, Huong Tran, Ngan Truong, Poonam Bhyan, Nguyen Tran, Phillip Tran
Journal: Journal of the American College of Cardiology (2022)
Mortality Associated With Mental Disorders and Comorbid General Medical Conditions
Authors: Natalie C. Momen, Oleguer Plana-Ripoll, Esben Agerbo, Maria K. Christensen, Kim Moesgaard Iburg, Thomas Munk Laursen, Preben B. Mortensen, Carsten B. Pedersen, Anders Prior, Nanna Weye, John J. McGrath
Journal: JAMA Psychiatry (2022)

<h3>Importance</h3> Premature mortality has been observed among people with mental disorders. Comorbid general medical conditions contribute substantially to this reduction in life expectancy. <h3>Objective</h3> To provide an analysis of mortality associated with comorbidity between a broad range of mental disorders and general medical conditions. <h3>Design, Setting, and Participants</h3> Population-based cohort study of 5 946 800 individuals born in Denmark from 1900 to 2015 and residing in the country at the start of follow-up (January 1, 2000, or their date of birth, whichever occurred later). <h3>Exposures</h3> Danish health registers were used to identify people with mental disorders and general medical conditions. <h3>Main Outcomes and Measures</h3> Considering pairs of mental disorders and general medical conditions, we calculated mortality rate ratios (MRRs) and differences in life expectancy (ie, life-years lost) to assess the association of mortality with both disorders of interest compared with the mental disorder of interest, the general medical condition of interest, and neither disorder of interest. <h3>Results</h3> The study population comprised 2 961 397 males and 2 985 403 females, with a median (IQR) age of 32.0 years (7.3-52.9) at start of follow-up and 48.9 years (42.5-68.8) at the end. Based on all pairs of comorbid mental disorders and general medical conditions, the mean MRR compared with people without these conditions was 5.90 (median, 4.94; IQR, 3.80-7.30), and the mean reduction of life expectancy compared with the general population was 11.35 years (median, 11.08; range, 5.27-23.53; IQR, 8.22-13.72). The association with general medical condition comorbidity in those with mental disorders varied by general medical condition; for example, the addition of a neurological condition for each of the mental disorders was associated with a mean MRR of 1.22, whereas for cancer, the mean MRR for all mental disorders was 4.07. <h3>Conclusions and Relevance</h3> In this study, shorter life expectancy was associated with comorbid mental disorders and general medical conditions compared with the entire population and also when compared with patients who had either mental disorders only or general medical conditions only. Prevention and early detection of comorbidities could reduce premature mortality in patients with mental disorders.
THE IMPACT OF GENDER ON OUTCOMES OF MECHANICAL CIRCULATORY SUPPORT IN PATIENTS HOSPITALIZED FOR HEART FAILURE: A NATIONWIDE ANALYSIS
Authors: Jose S. Aguilar-Gallardo, Lady Njemeh Danso, Francisco Romeo, Marta Lorente-Ros, Alba Munoz Estrella, Johanna Paola Contreras, Mount Sinai Morningside
Journal: Journal of the American College of Cardiology (2022)
A COMPARATIVE META-ANALYSIS OF DISTAL RADIAL VS. TRADITIONAL RADIAL PERCUTANEOUS CORONARY INTERVENTION OR ANGIOGRAPHY: A REGRESSION-BASED ANALYSIS
Authors: Yasar Sattar, Usama Talib, Mohammed Faisaluddin, David Song, Hassan Mehmood Lak, Aamir Laghari, Muhammad Z. Khan, Waqas Ullah, Mohamed Zghouzi, Islam Elgendy, Sudarshan Balla, Ramesh Babu Daggubati, Akram Kawsara, Hani Jneid, M. Chadi Alraies, Mahboob Alam
Journal: Journal of the American College of Cardiology (2022)
ALL-CAUSE MORTALITY IN CATHETER ABLATION VERSUS ANTIARRHYTHMIC MEDICAL THERAPY IN PATIENTS WITH ATRIAL FIBRILLATION - A SYSTEMATIC REVIEW AND META-ANALYSIS
Authors: Radhika Deshpande, Prashanth Singanallur, Yasser AlKhadra, Albert Botchway, Nour Albast, Raad Al-Tamimi, Manasik Abdu, Basma Al-Bast, Mohamed Rafa Labedi
Journal: Journal of the American College of Cardiology (2022)
Abstract P1-21-05: GM-CSF is an autocrine driver of HER2+ breast leptomeningeal carcinomatosis
Authors: Arunoday Kuldeep Bhan, Khairul I Ansari, Clara Chen, Rahul Jandial
Journal: Cancer Research (2022)

Abstract Leptomeningeal carcinomatosis (LC) occurs when tumor cells spread to the cerebrospinal fluid containing leptomeninges surrounding the brain and spinal cord. LC is an ominous complication of cancer with a dire prognosis. Although any malignancy can spread to the leptomeninges, breast cancer, particularly the HER2+ subtype, is its most common origin. HER2+ breast LC (HER2+ LC) remains incurable, with few treatment options, and the molecular mechanisms underlying proliferation of HER2+ breast cancer cells in the acellular, protein, and cytokine-poor leptomeningeal environment remain elusive. Therefore, we sought to characterize signaling pathways that drive HER2+ LC development as well as those that restrict its growth to leptomeninges. Primary HER2+ LC patient-derived ("Lepto") cell lines in co-culture with various central nervous system (CNS) cell types revealed that oligodendrocyte progenitor cells (OPC), the largest population of dividing cells in the CNS, inhibited HER2+ LC growth in vitro and in vivo, thereby limiting the spread of HER2+ LC beyond the leptomeninges. Cytokine array-based analyses identified Lepto cell-secreted granulocyte-macrophage colony-stimulating factor (GM-CSF) as an oncogenic autocrine driver of HER2+ LC growth. Liquid chromatography-tandem mass spectrometry-based analyses revealed that the OPC-derived protein TPP1 proteolytically degrades GM-CSF, decreasing GM-CSF signaling and leading to suppression of HER2+ LC growth and limiting its spread. Lastly, intrathecal delivery of neutralizing anti-GM-CSF antibodies and a pan-Aurora kinase inhibitor (CCT137690) synergistically inhibited GM-CSF and suppressed activity of GM-CSF effectors, reducing HER2+ LC growth in vivo. Thus, OPC suppress GM-CSF-driven growth of HER2+ LC in the leptomeningeal environment, providing a potential targetable axis. Citation Format: Arunoday Kuldeep Bhan, Khairul I Ansari, Clara Chen, Rahul Jandial. GM-CSF is an autocrine driver of HER2+ breast leptomeningeal carcinomatosis [abstract]. In: Proceedings of the 2021 San Antonio Breast Cancer Symposium; 2021 Dec 7-10; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2022;82(4 Suppl):Abstract nr P1-21-05.
Tyrosine phosphatase SHP2 exacerbates psoriasis‐like skin inflammation in mice via ERK5‐dependent NETosis
Authors: Yan Ding, Zijun Ouyang, Chenyang Zhang, Yuyu Zhu, Qiang Xu, Haiyan Sun, Jiao Qu, Yang Sun
Journal: MedComm (2022)

Psoriasis is a chronic inflammatory skin disease, often accompanied by increased infiltration of immune cells, especially neutrophils. However, the detailed mechanism of the neutrophil function in psoriasis progression remains unclear. Here, we found that both Src homology-2 domain-containing protein tyrosine phosphatase-2 (SHP2) and neutrophils were highly correlated to developing psoriasis by single-cell ribonucleic acid (RNA) sequencing and experiment verification. The deficiency of SHP2 in neutrophils significantly alleviated psoriasis-like phenotype in an imiquimod-induced murine model. Interestingly, high levels of neutrophil extracellular traps (NETs) were produced in the inflamed lesions of psoriatic patients. In addition, imiquimod-induced psoriasis-like symptoms were remarkably ameliorated in peptidyl arginine deiminase 4 (PAD4) knockout mice, which cannot form NETs. Mechanistically, RNA-seq analysis revealed that SHP2 promoted the formation of NETs in neutrophils via the ERK5 pathway. Functionally, this mechanism resulted in the infiltration of pro-inflammatory cytokines such as TNF-α, IL-1β, IL-6, IL-17A, and CXCL-15, which enhances the inflammatory response in skin lesions and reinforces the cross-talk between neutrophils and keratinocytes, ultimately aggravating psoriasis. Our findings uncover a role for SHP2 in NET release and subsequent cell death known as NETosis in the progression of psoriasis and suggest that SHP2 may be a promising therapeutic target for psoriasis.
THE USE OF VENO-ARTERIAL ECMO IN A COVID-19 PATIENT WITH CARDIOGENIC SHOCK: A LIFE WAS SAVED
Authors: Ahmed Hussein, Amr Salama, Abdullah Abdullah, Adnan Kharsa, Saarwaani Vallabhajosyula, Vishal Yogin Parikh, Elizabeth Lee, Soidjon D. Khodjaev, Scott Clinton Feitell, Cameron Hall
Journal: Journal of the American College of Cardiology (2022)
Unusual 68Ga-DOTATATE Uptake in Primary Nodal Hemangioma of Axillary Lymph Node
Authors: Hatice Sariyildiz Gumusgoz, Zeynep Burak, Burcin Karasah Erkek
Journal: Clinical Nuclear Medicine (2022)

68 Ga-DOTATATE PET/CT is a well-known modality in diagnosis, staging, and in predicting therapy response of neuroendocrine tumors. We present a case of 63-year-old woman with diagnosis of pancreas neuroendocrine tumor showing 68 Ga-DOTATATE uptake in a lymph node in left axilla. It was diagnosed as capillary hemangioma after biopsy. 68 Ga-DOTATATE uptake in bone hemangiomas is well-known; however, its uptake in a nodal hemangioma is worth to know as it might change the clinical perspective.
COMMANDO SURGERY AS THE THIRD REOPERATION OF A RHEUMATIC PATIENT WITH SEVERE MITRAL-AORTIC-PROSTHESIS DYSFUNCTION AND MISMATCH: A CASE REPORT
Authors: Amanda Bergamo Mazetto, Rallyson De Oliveira Gonçalves, Julien Ramos Stein, Tarso Augusto Accorsi, Samuel Padovani Steffen, Flavio Tarasoutchi, Aroni Marcéu Sousa e Rocha, Ana Flávia Diez de Andrade, Joaquim Tenente Ana de Campos, Fabio Antonio Gaiotto
Journal: Journal of the American College of Cardiology (2022)
BASELINE COMORBIDITIES AND BLEEDING EVENTS OF PATIENTS UNDERGOING PERCUTANEOUS LEFT ATRIAL APPENDAGE OCCLUSION AMONG MEDICARE BENEFICIARIES
Authors: Michael Blotner, Mohammed Ruzieh, Nicole Smolinski, Scott Vouri, Gerald V. Naccarelli, John Mandrola, Andrew J. Foy
Journal: Journal of the American College of Cardiology (2022)
TRENDS IN CHARACTERISTICS AND OUTCOMES OF PERIPARTUM CARDIOMYOPATHY HOSPITALIZATIONS IN THE UNITED STATES BETWEEN 2004-2018
Authors: Sardar Ijaz, Shakeel Jamal, Abdul Mannan Khan Minhas, Abu Baker Sheikh, Salik Nazir, Muhammad Shahzeb Khan, Anum Minhas, Allison G. Hays, Haider Javed Warraich, Stephen Greene, Marat Fudim, Michael Honigberg, Sadiya Sana Khan, Timir K. Paul, Erin D. Michos
Journal: Journal of the American College of Cardiology (2022)
IMPACT OF INTERHOSPITAL TRANSFER ON OUTCOMES IN ACUTE PULMONARY EMBOLISM
Authors: Merry Ellen Barnett, Grant O. Lardieri, Jasmine K. Malhi, Jackson A. Narrett, Chad M. Aldridge, Randy K. Ramcharitar, Andrew D. Mihalek, Alexandra Kadl, Sula Mazimba, John F. Angle, Taison D. Bell, Ziv Haskal, Prerna S. Sharma, Nicholas R. Teman, Louise M. Man, Minhajuddin S. Khaja, Aditya M. Sharma
Journal: Journal of the American College of Cardiology (2022)
1P Sitravatinib + tislelizumab in patients with anti-PD-(L)1 refractory/resistant metastatic non-small cell lung cancer (NSCLC)
Authors: B. Gao, Z. Ma, X. Yu, D. Huang, J. Zhao, D. Day, A.L. Body, Q. Zhou, Q. Chu, H. Pan, J. Cui, H. Li, J. Sun, J. Zhang, C. Fei, Y-L. Wu
Journal: Annals of Oncology (2022)
EARLY CARDIOVASCULAR RISK AFTER AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANT FOR MULTIPLE MYELOMA
Authors: Montserrat Carrillo Estrada, Gazelle Halajha, Donna Reece, Coleen Power, Esther Masih-Khan, Paul Harminder, Douglas S. Lee, Paaladinesh Thavendiranathan, Husam Abdel-Qadir
Journal: Journal of the American College of Cardiology (2022)